Nuvation Bio Inc. (NUVB)
NYSE: NUVB · Real-Time Price · USD
4.750
+0.070 (1.50%)
At close: Oct 15, 2026, 4:00 PM EDT
4.700
-0.050 (-1.05%)
After-hours: Oct 15, 2026, 7:43 PM EDT
Nuvation Bio Stock Forecast
Stock Price Forecast
According to 13 analysts polled by S&P Global, Nuvation Bio stock has a consensus rating of "Strong Buy" and an average price target of $13. The average 1-year stock price forecast is 173.68% higher than the current stock price, while the lowest is $7.00 (+47.37%) and the highest is $21 (+342.11%).
Price Target: $13 (+173.68%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Nuvation Bio stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 7 | 8 | 9 | 9 |
| Buy | 2 | 2 | 2 | 3 | 3 | 3 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 10 | 12 | 13 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Maintains $20 | Buy | Maintains | $20 | +321.05% | Oct 9, 2026 |
| Citi | Citi | Buy Initiates $12 | Buy | Initiates | $12 | +152.63% | Sep 30, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Sep 15, 2026 |
| Wedbush | Wedbush | Buy Maintains $11 | Buy | Maintains | $11 | +131.58% | Sep 15, 2026 |
| Truist Financial | Truist Financial | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Sep 15, 2026 |
Financial Forecast
Revenue This Year
196.12M
from 62.90M
Increased by 211.79%
Revenue Next Year
284.68M
from 196.12M
Increased by 45.15%
EPS This Year
-0.29
from -0.49
EPS Next Year
-0.02
from -0.29
EPS and Forward PE are based on non-GAAP adjusted numbers.